Spring direct naar de hoofdnavigatie of de inhoud

Frits Michiels

Patent attorney

“To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.”
Home / Experts / Frits Michiels

Frits Michiels

Frits Michiels

  • Life Sciences
  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

More information about Frits

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

Marijke Westra

Marijke Westra

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
Hajo Kraak

Hajo Kraak

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
More experts

News

V.O. organises European Patent Seminar in Munich

Our firm is once again organising another European Patent Seminar in Munich between 23 and 25 September.Continue reading

VoiceMint patent a prototype of ingenuity

A buzzword at education and research institutes for some time now has been ‘valorisation’. This means rendering academic knowledge suitable and/or usable for economic and social benefit. A great example is the invention of the VoiceMint, a device that makes it possible to talk without using the vocal chords.Continue reading

V.O. supports students through innovation competitions

The universities of Delft, Eindhoven, Twente and Wageningen have joined one another in setting up innovation competitions.Continue reading

Events

Product case game: Heineken THE SUB

TU Delft Faculty 3mE, Instruction room L, Mekelweg 2, Delft, Netherlands

Exclusively for TU Delft students we, together with Vattenfall Solar Team, organize a special product case game. Make a deep dive into the innovative world of home draught beer with Heineken’s THE SUB. Via this game you will gain insight into the role of Intellectual Property during the development of this stunning device. And not in the least place, how a multinational reduced its carbon footprint. Win the game and THE SUB is yours! More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event

INTA Annual Meeting 2019

Boston Convention and Exhibition Center, Summer Street, Boston, Massachusetts, United States

The INTA Annual Meeting is the largest and most influential gathering of brand owners and intellectual property (IP) professionals from around the world and from across industries. Join the 141st Annual Meeting in Boston, Massachusetts, May 18‒22, 2019, and you’ll leave with fresh perspectives, critical insights, best practices, and knowledge about new market trends to drive your organization forward. More about this event